---
title: "003017.SZ (003017.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/003017.SZ/news.md"
symbol: "003017.SZ"
name: "003017.SZ"
parent: "https://longbridge.com/en/quote/003017.SZ.md"
datetime: "2026-05-20T18:47:33.423Z"
locales:
  - [en](https://longbridge.com/en/quote/003017.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/003017.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/003017.SZ/news.md)
---

# 003017.SZ (003017.SZ) — Related News

### [DAYANG BIOTECH: The concerted party of the actual controller plans to reduce its holdings by no more than 0.63% of the shares](https://longbridge.com/en/news/286906217.md)
*2026-05-19T11:48:08.000Z*
> DAYANG BIOTECH announced that the concerted parties of the actual controller plan to reduce their holdings by no more th

### [DAYANG BIOTECH: Net profit is expected to grow by 56.64% year-on-year in 2025, proposing a 10-for-2 stock split and a dividend of 3 yuan](https://longbridge.com/en/news/284208941.md)
*2026-04-27T11:51:44.000Z*
> DAYANG BIOTECH (003017) released its annual report, expecting an operating income of CNY 1.045 billion in 2025, a year-o

### [](https://longbridge.com/en/news/282472052.md)
*2026-04-13T01:50:25.000Z*
> On April 13th, DAYANG BIOTECH stated on the interactive platform that the company does not yet possess the production te

### [EVEREST MED signs acquisition agreement with Haisen Biotech to expand its commercial footprint in the Asia-Pacific region](https://longbridge.com/en/news/281942755.md)
*2026-04-07T23:35:03.000Z*
> EVEREST MED has signed an acquisition agreement with Haisen Biotech to acquire all the shares of Haisen Singapore, with 

### [](https://longbridge.com/en/news/281818527.md)
*2026-04-07T02:14:00.000Z*
> The animal health concept has rebounded sharply, with Shen Lian Biomedical hitting the limit up, and CAHIC, Hengtong, DA

### [DAYANG BIOTECH: The food additive project is expected to be completed and put into production in the first half of 2026](https://longbridge.com/en/news/277897851.md)
*2026-03-05T07:38:27.000Z*
> On March 5th, DAYANG BIOTECH stated on the interactive platform that the company's food additive project is currently un

### [Foreign capital sees growth and raises targets, Chi Hung's stock price surges over 2.5%](https://longbridge.com/en/news/276965430.md)
*2026-02-26T01:21:41.000Z*
> Foreign investors are optimistic about Qihong (3017) operations, raising the target price to NT$1,730, with the stock pr

### [DAYANG BIOTECH: Zhejiang Xinzhi Chun's products are in direct contact with wafers and are currently still in the verification process](https://longbridge.com/en/news/273011693.md)
*2026-01-20T00:53:43.000Z*
> On January 20th, DAYANG BIOTECH stated on the interactive platform that the products produced by Zhejiang Xinzhi Chun co

### [DAYANG BIOTECH issued a profit forecast, expecting a year-on-year increase of 50.60%—72.56% in net profit attributable to the parent company for the fiscal year 2025](https://longbridge.com/en/news/271415743.md)
*2026-01-04T08:59:04.000Z*
> DAYANG BIOTECH released its performance forecast for 2025, expecting a net profit attributable to the parent company of